- Mandibular midline osteotomy for correction of bimaxillary transverse discrepancy: a technical note
-
Ramanathan M, Sonoyama-Osako R, Shimamura Y, Okui T, Kanno T
- KMID: 2544312
- J Korean Assoc Oral Maxillofac Surg.
- 2023 Jun;49(3):107-113.
- doi: 10.5125/jkaoms.2023.49.3.107
Bimaxillary transverse width discrepancies are commonly encountered among patients with dentofacial deformities. Skeletal discrepancies should be diagnosed and managed appropriately with possible surgical corrections. Transverse width deficiencies can present in... -
- CITED
-
- Close
- SHARE
-
- Close
- Spontaneous Regression of a Large Hepatocellular Carcinoma with Multiple Lung Metastases
-
Saito T, Naito M, Matsumura , Kita H, Kanno T, Nakada Y, Hamano M, Chiba M, Maeda K, Michida T, Ito T
- KMID: 2070069
- Gut Liver.
- 2014 Sep;8(5):569-574.
- doi: 10.5009/gnl13358
A 75-year-old Japanese man with chronic hepatitis C was found to have a large liver tumor and multiple nodules in the bilateral lungs. We diagnosed the tumor as hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Extremely-slow, half-number shockwave lithotripsy for asymptomatic renal stones <20 mm
-
Ito K, Takahashi T, Kanno T, Okada T, Higashi Y, Yamada H
- KMID: 2509854
- Investig Clin Urol.
- 2021 Jan;62(1):72-78.
- doi: 10.4111/icu.20200285
Purpose: To compare the treatment success rate and safety of reduced (30 shocks/min, 1,200 shocks/session) versus standard (60 shocks/min, 2,400 shocks/session) extracorporeal shockwave lithotripsy for the management of renal stones. Materials... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
-
Kanno T, Matsui H, Akizawa Y, Usui H, Shozu M
- KMID: 2431234
- J Gynecol Oncol.
- 2018 Nov;29(6):e89.
- doi: 10.3802/jgo.2018.29.e89
OBJECTIVE: Highly effective chemotherapy for patients with low-risk gestational trophoblastic neoplasia (GTN) is associated with almost a 100% cure rate. However, 20%–30% of patients treated with chemotherapy need to change... -
- CITED
-
- Close
- SHARE
-
- Close
